Skip to main content
Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
0.494
+0.004 (0.75%)
At close: Nov 20, 2024, 4:00 PM
0.481
-0.013 (-2.71%)
After-hours: Nov 20, 2024, 7:59 PM EST

Amarin Corporation Revenue

Amarin Corporation had revenue of $42.30M in the quarter ending September 30, 2024, a decrease of -35.97%. This brings the company's revenue in the last twelve months to $241.02M, down -25.25% year-over-year. In the year 2023, Amarin Corporation had annual revenue of $306.91M, down -16.87%.

Revenue (ttm)
$241.02M
Revenue Growth
-25.25%
P/S Ratio
0.84
Revenue / Employee
$876,440
Employees
275
Market Cap
203.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023306.91M-62.28M-16.87%
Dec 31, 2022369.19M-213.99M-36.69%
Dec 31, 2021583.19M-30.87M-5.03%
Dec 31, 2020614.06M184.31M42.89%
Dec 31, 2019429.76M200.54M87.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 141.33M
SOPHiA GENETICS 64.49M
Molecular Partners AG 7.11M
Orchestra BioMed Holdings 2.65M
Inhibrx Biosciences 1.57M
Sera Prognostics 94.00K
Revenue Rankings

AMRN News

More News